Andrzej Mital

1.4k total citations
48 papers, 369 citations indexed

About

Andrzej Mital is a scholar working on Hematology, Genetics and Immunology. According to data from OpenAlex, Andrzej Mital has authored 48 papers receiving a total of 369 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Hematology, 21 papers in Genetics and 8 papers in Immunology. Recurrent topics in Andrzej Mital's work include Platelet Disorders and Treatments (18 papers), Hemophilia Treatment and Research (16 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (9 papers). Andrzej Mital is often cited by papers focused on Platelet Disorders and Treatments (18 papers), Hemophilia Treatment and Research (16 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (9 papers). Andrzej Mital collaborates with scholars based in Poland, Croatia and Czechia. Andrzej Mital's co-authors include Andrzej Hellmann, Witold Prejzner, Maria Bieniaszewska, Andrzej Hellmann, Krzysztof Lewandowski, Tomasz Smiatacz, Miłosz Jaguszewski, Piotr Trzonkowski, Bartosz Wasąg and Renata Świątkowska−Stodulska and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and British Journal of Haematology.

In The Last Decade

Andrzej Mital

41 papers receiving 357 citations

Peers

Countries citing papers authored by Andrzej Mital

Since Specialization

Citations

This map shows the geographic impact of Andrzej Mital's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrzej Mital with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrzej Mital more than expected).

Fields of papers citing papers by Andrzej Mital

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrzej Mital. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrzej Mital. The network helps show where Andrzej Mital may publish in the future.

Co-authorship network of co-authors of Andrzej Mital

This figure shows the co-authorship network connecting the top 25 collaborators of Andrzej Mital. A scholar is included among the top collaborators of Andrzej Mital based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrzej Mital. Andrzej Mital is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Zanubrutinib: a novel therapeutic option for the treatment of B-cell neoplasms 2023 ·Acta Haematologica Polonica ·(unknown), (unknown), Marcin Okrój, (unknown), Andrzej Mital	2
2	A phase 1b/2 clinical study of marstacimab, targeting human tissue factor pathway inhibitor, in haemophilia 2022 ·British Journal of Haematology ·Johnny Mahlangu, (unknown), (unknown), Daniel R Malan, Silva Zupančić Šalek, Michael Wang, Lisa Boggio, Inga Hegemann, Andrzej Mital, Matthew Cardinal, Tong Zhu, Pengling Sun, Steven Arkin	28
3	Real-World Efficacy of Midostaurin in Aggressive Systemic Mastocytosis 2021 ·Journal of Clinical Medicine ·(unknown), (unknown), (unknown), (unknown), Andrzej Mital, Michał Szczyrek, Witold Krupski, Justyna Szumiło, (unknown), Grzegorz Helbig, Marek Hus	10
4	Excessive amount and activity of μ-calpain affects apoptotic machinery in chronic B-cell leukemia cells and influences the course of the disease 2020 ·Acta Biochimica Polonica ·(unknown), (unknown), Andrzej Mital, (unknown), (unknown), Andrzej Hellmann, Agnieszka Daca, Ewa Bryl, Tamàs Fülöp, Jacek M. Witkowski	2
5	Zaawansowana mastocytoza układowa — stanowisko ekspertów dotyczące postępowania diagnostycznego i leczniczego 2019 ·Jagiellonian University Repository (Jagiellonian University) ·Grzegorz Helbig, Tomasz Sacha, Andrzej Mital, Marek Hus, (unknown), Krystyna Gałązka, (unknown), Marta Sobas, (unknown), (unknown)	0
6	Genetic and clinical characterization of congenital fibrinogen disorders in Polish patients: Identification of three novel fibrinogen gamma chain mutations 2019 ·Thrombosis Research ·Ewa Wypasek, Anna Klukowska, (unknown), Krystyna Zawilska, Jacek Treliński, Teresa Iwaniec, Andrzej Mital, (unknown), Wojciech Sydor, Marguerite Neerman‐Arbez, Anetta Undas	16
7	Acquired von Willebrand Syndrome 2016 ·Advances in Clinical and Experimental Medicine ·Andrzej Mital	27
8	Red Blood Cell Transfusion Dependency and Hyperferritinemia Are Associated with Impaired Survival in Patients Diagnosed with Myelodysplastic Syndromes: Results from the First Polish MDS-PALG Registry 2016 ·Advances in Clinical and Experimental Medicine ·Anna Waszczuk‐Gajda, Krzysztof Mądry, Rafał Machowicz, Joanna Drozd‐Sokołowska, Beata Stella‐Hołowiecka, Andrzej Mital, (unknown), Anna Szmigielska‐Kapłon, A. Sikorska, Edyta Subocz, W Wiktor-Jędrzejczak, Jadwiga Dwilewicz‐Trojaczek	14
9	Acquired von Willebrand Syndrome During the Course of Myelofibrosis: Analysis of 32 Cases 2016 ·Advances in Clinical and Experimental Medicine ·Andrzej Mital, Witold Prejzner, Andrzej Hellmann	8
10	Ocena funkcji płytek krwi u pacjentów z endogenną hiperkortyzolemią 2015 ·Endokrynologia Polska ·Renata Świątkowska−Stodulska, Andrzej Mital, Piotr Wiśniewski, Anna Babińska, (unknown), Krzysztof Sworczak	6
11	Polish experience of lenalidomide in the treatment of lower risk myelodysplastic syndrome with isolated del(5q) 2015 ·BMC Cancer ·Aleksandra Butrym, Ewa Lech‐Marańda, Elżbieta Patkowska, (unknown), Maria Bieniaszewska, Andrzej Mital, Krzysztof Mądry, Tigran Torosian, (unknown), Justyna Rybka, Krzysztof Warzocha, Grzegorz Mazur	6
12	Factors predisposing to acquired von Willebrand syndrome during the course of polycythemia vera – retrospective analysis of 142 consecutive cases 2015 ·Thrombosis Research ·Andrzej Mital, Witold Prejzner, Renata Świątkowska−Stodulska, Andrzej Hellmann	21
13	Polskie zalecenia dotyczące leczenia antagonistami witaminy K 2013 ·Via Medica Journals ·Andrzej Mital, Magdalena Łętowska, Krzysztof Chojnowski, Anna Klukowska, Jacek Musiał, Maria Podolak‐Dawidziak, Jarosław Peregud‐Pogorzelski, Jacek Treliński, Anetta Undas, Jerzy Windyga, (unknown), Krystyna Zawilska	0
14	Polish guidelines for the management of rare clotting factor deficiencies 2011 ·Via Medica Journals ·Krystyna Zawilska, Krzysztof Chojnowski, Anna Klukowska, Magdalena Łętowska, Andrzej Mital, Jacek Musiał, Maria Podolak‐Dawidziak, Anetta Undas, Jerzy Windyga, (unknown)	2
15	A case of mast cell leukaemia with exon 9 KIT mutation and good response to imatinib 2011 ·European Journal Of Haematology ·Andrzej Mital, Anna Piskorz, Krzysztof Lewandowski, Bartosz Wasąg, Janusz Limon, Andrzej Hellmann	38
16	Registry of inherited bleeding disorders in Poland – current status and potential role of the HemoRec database 2010 ·Haemophilia ·(unknown), Krzysztof Chojnowski, Anna Klukowska, Magdalena Łętowska, Andrzej Mital, Jacek Musiał, Maria Podolak‐Dawidziak, Jerzy Windyga, Petra Ovesná, Petr Brabec, Krystyna Zawilska	13
17	Single‐dose (270 μg kg⁻¹) recombinant activated factor VII for the treatment and prevention of bleeds in haemophilia A patients with inhibitors: experience from seven European haemophilia centres 2009 ·Haemophilia ·Brigitte Pan‐Petesch, Paweł Łaguna, Andrzej Mital, Jeffrey J. Stanley, M.‐F. Torchet, Silva Zupančić Šalek, Peter Salaj	16
18	Influence of Chromosomal Aberrations on Response to First Line Therapy in B-Cell Chronic Lymphocytic Leukemia: Interim Analysis of PALG-CLL3 Randomized Study Comparing Cladribine Plus Cyclophosphamide vs Fludarabine Plus Cyclophosphamide. 2007 ·Blood ·Tadeusz Robak, Jerzy Z. Błoński, Ewa Wawrzyniak, (unknown), Joanna Góra‐Tybor, Krzysztof Jamroziak, Jarosław Piszcz, Janusz Kłoczko, (unknown), Małgorzata Kowal, Anna Dmoszyńska, Andrzej Mital, Andrzej Hellmann	1
19	Necrotizing Enterocolitis in Acute Lymphoblastic Leukemia Patients: Department Experience 2005 ·International Journal of Hematology ·Stanisław Hać, (unknown), Andrzej Mital, (unknown)	1
20	Addition of Cladribine to Induction/Consolidation Regimen Does Not Impair Peripheral Blood Stem Cell Mobilization and Bone Marrow Harvest for Autotransplantation in Acute Myeloid Leukemia Patients 2005 ·Transplantation Proceedings ·Jerzy Hołowiecki, Sebastian Grosicki, Maria Saduś‐Wojciechowska, (unknown), Andrzej Hellmann, Andrzej Mital, A B Skotnicki, Beata Piątkowska‐Jakubas, W Wiktor-Jędrzejczak, Monika Paluszewska, Małgorzata Wach, (unknown), Agata Wrzesień‐Kuś, Małgorzata Krawczyk‐Kuliś, Jerzy Wojnar	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact